Pacific Edge (NZX:PEB)
ASX announcement history & article coverage
Transparent by design.
Announcments by Pacific Edge (NZX:PEB) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Capital Change Notice - Pacific Edge Limited - 8 July 26
Director Nomination Closing Date
Annual Report 2026
Pacific Edge reports FY26 loss amid Medicare coverage loss; draft LCD signals Medicare coverage return and growth potential
D&O Disclosure - Tony Barclay
D&O Disclosure - Sarah Park
D&O Disclosure - Anna Stove
D&O Disclosure - Grant Gibson
D&O Disclosure - Peter Meintjes
SPH Notice - ANZ New Zealand Investments Limited, ANZ Bank New Zealand Limited and ANZ Custodial Services New Zealand Limited
ASX - 2A - Employee Shares
ASX - 2A - Shares for Legal Services
ASX - 2A - Retail Offer
Capital Change Notice - Pacific Edge Limited
PEB Completes Oversubscribed NZ$36.1m Capital Raise
Pacific Edge raises NZ$36.1 million in oversubscribed capital raising to support Cxbladder growth
SPH Notice - Harbour Asset Management Limited
Retail Offer Reminder
Pacific Edge Retail Offer Oversubscribed, Scaling Likely as NZ$6 Million Raise Closes 28 May
FY26 Audited Results - Presentation
Pacific Edge FY26 revenue down 47% amid Medicare non-coverage; Medicare draft LCD proposes coverage for Cxbladder tests, unlocking US market potential
FY26 Audited Results - Equity & Debit
Pacific Edge reports 47% revenue drop and 20% larger net loss for FY2026, no dividends declared
FY26 Audited Results - Financial Statements
Pacific Edge reports $35.8m loss, revenue halved after Medicare coverage loss; raises $25.4m capital, seeks to regain US Medicare coverage
FY26 Audited Results - Announcement
Pacific Edge reports FY26 loss amid Medicare coverage loss but gains draft Medicare coverage for Cxbladder tests, raising NZ$25.4 million to support growth
D&O Disclosure - Anatole Masfen 2
D&O Disclosure - Simon Flood
D&O Disclosure - Bryan Williams
D&O Disclosure - Anatole Masfen 1
SPH Notice - ANZ New Zealand Investments Limited
ASX - 2A - Pacific Edge Placement
Pacific Edge Limited completes placement, 149 million shares quoted at NZD 0.17
Capital Change Notice - Issue of Shares - Placement
Draft LCD Proposes Medicare Coverage for Triage and Triage
Medicare Draft LCD Proposes Coverage for Pacific Edge's Cxbladder Tests in Microhematuria
Retail Offer Announcement - Pacific Edge Opens Retail Offer
Pacific Edge launches NZ$6 million retail offer after NZ$25.4 million placement to fund growth and Medicare re-coverage
Retail Offer Application Form
Pacific Edge launches NZ retail share offer with direct debit application by 28 May 2026
Retail Offer Document
Pacific Edge launches NZ$6 million retail share offer at NZ$0.170 to support US Medicare re-coverage and growth
Pacific Edge Limited (“PEB”) – Trading to resume
Pacific Edge Placement Increased to NZ$25.4 Million
Pacific Edge raises NZ$25.4 million in oversubscribed placement to support growth and Medicare re-coverage
Pacific Edge FY26 Result to be Announced 25 May 2026
PEB - Trading Halt Application
PEB – Trading Halt of Securities
Pacific Edge Capital Raising Presentation - 8 May 2026
Pacific Edge launches NZ$24m capital raise to support Medicare re-coverage and commercial growth amid FY26 revenue decline
ASX 3B - Pacific Edge Capital Raise
Pacific Edge Limited announces NZD 23 million capital raise via securities purchase plan and placement
Pacific Edge - Cleansing Notice
Pacific Edge Limited to raise NZ$24 million via non-underwritten share offer
Pacific Edge - Corporate Action Notice
Pacific Edge launches NZ$24 million placement and share purchase plan to support growth
Pacific Edge Launches Capital Raise of NZ$24 Million
Pacific Edge launches NZ$24 million capital raise amid Medicare coverage challenges and anticipates positive Medicare draft LCD by September 2026